Veronica Dilworth
Family · Midlothian, TXNPI 1275044711
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 36.0% of the total. Reporting peaked in 2023 at $968 and has fallen 60.7% since, to $381 in 2025.
Across 118 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$865
- Astellas Pharma US Inc$242
- AstraZeneca$223
- Corium, LLC$192
- Lilly USA, LLC$134
- Otsuka America Pharmaceutical, Inc.$79
- plus $668 from 20 others
What the payments were for
- Food & beverage$2,23593%
- Education$1416%
- Other$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $865 |
| Astellas Pharma US Inc | 9 | $242 |
| AstraZeneca | 8 | $223 |
| Corium, LLC | 8 | $192 |
| Lilly USA, LLC | 8 | $134 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| GSK | 5 | $70 |
| Noven Therapeutics, LLC | 4 | $68 |
| Novo Nordisk | 4 | $60 |
| Pfizer | 3 | $54 |
| Amgen(2 entities) | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Boston Scientific | 1 | $35 |
| Dexcom, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Baxter Healthcare | 1 | $27 |
| Bayer | 1 | $23 |
| Abbott | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| IBSA Pharma Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$110
How this compares
$2,403 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Midlothian
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.